BP000123-CYT-393: Recombinant Rat Tumor Necrosis Factor-α (TNFα) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is < 0.05 ng/ml, corresponding to a Specific Activity of 20 MIU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000123-CYT-405: Recombinant Porcine Tumor Necrosis Factor-α (TNFα) Protein
Source: E. coli-derived.
The ED50 as determined by the cytotoxicity of porcine PK15 cells was found to be 0.001-0.015 ng/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000123-CYT-494: Recombinant Human Tumor Necrosis Factor-α (TNFα) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000123-CYT-114: Recombinant Human Tumor Necrosis Factor-Alpha (TNFα) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent cytotoxity of the TNF alpha sensitive cell line L-929 in the presence of Actinomycin D and is typically 0.05-0.5 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000123-CYT-140: Recombinant Canine Tumor Necrosis Factor-Alpha (TNFα) Protein
Source: E. coli-derived.
The Specific Activity is >3.3?05 IU/mg as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000123-CYT-384: Recombinant Human Tumor Necrosis Factor α Mutant
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is < 0.05 ng/ml, corresponding to a Specific Activity of 20,000,000 units/mg.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000123-GD22: Recombinant Human Tumor Necrosis Factor alpha (TNFα) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is less than 0.03 ng/ml. Specific Activity of 3.0 x 10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).